Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $100000.0.

  • InMed Pharmaceuticals' Other Non-Current Assets changed 0.0% to $100000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $100000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $100000.0 for FY2025, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2025, InMed Pharmaceuticals' Other Non-Current Assets is $100000.0, which was down 0.0% from $100000.0 recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Other Non-Current Assets ranged from a high of $176637.0 in Q2 2022 and a low of $8625.0 during Q3 2021
  • In the last 5 years, InMed Pharmaceuticals' Other Non-Current Assets had a median value of $100000.0 in 2023 and averaged $111083.8.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Other Non-Current Assets surged by 188411.59% in 2022, and later tumbled by 4156.49% in 2023.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Other Non-Current Assets stood at $109175.0 in 2021, then skyrocketed by 56.75% to $171130.0 in 2022, then tumbled by 41.56% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Its Other Non-Current Assets was $100000.0 in Q4 2025, compared to $100000.0 in Q3 2025 and $100000.0 in Q2 2025.